SCHEMBL31346183

SCHEMBL31346183

O=C(O)c1cccc(C2Cc3cc(-c4cccnc4)ccc3O2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 1/20 0.56
MKNK1 Q9BUB5 1/20 0.46
MKNK2 Q9HBH9 1/20 0.46
FFAR1 O14842 2/20 0.43
ABL1 P00519 2/20 0.42
BCR P11274 2/20 0.42
IP6K1 Q92551 1/20 0.42
IP6K3 Q96PC2 1/20 0.42
IP6K2 Q9UHH9 1/20 0.42
PRKCA P17252 1/20 0.42
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
CYP11B2 P19099 7/20 0.41
CYP11B1 P15538 6/20 0.41
CYP1A2 P05177 2/20 0.41
PIK3CA P42336 1/20 0.41
PIM1 P11309 1/20 0.41
PIM2 Q9P1W9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31345982 0.82 ALDH1A1 (0.44) KMOFFAR1ALDH1A1TDP1
SCHEMBL31346085 0.80 ALDH1A1 (0.42) KMOFFAR1ALDH1A1TDP1GRIA2
SCHEMBL31346172 0.77 ALDH1A1 (0.48) KMOFFAR1ALDH1A1TDP1
SCHEMBL29569537 0.74 KMO (1.00) KMOMKNK1MKNK2ABL1BCR
SCHEMBL206541 0.74 KMO (1.00) KMOMKNK1MKNK2ABL1BCR
SCHEMBL28297133 0.74 KMO (1.00) KMOMKNK1MKNK2ABL1BCR
SCHEMBL31346099 0.74 CFTR (0.49) KMOFFAR1ALDH1A1TDP1
SCHEMBL31346163 0.74 TDP1 (0.47) KMOFFAR1ALDH1A1TDP1
SCHEMBL31345978 0.74 CFTR (0.49) KMOFFAR1ALDH1A1TDP1
SCHEMBL31346052 0.74 TDP1 (0.47) KMOFFAR1ALDH1A1KDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4712967-A2 G-PROTEIN COUPLED RECEPTOR ANTAGONIST Enveda Therapeutics, Inc. (US) 2026-03-25 EP disclosed
WO-2024239000-A2 G-PROTEIN COUPLED RECEPTOR ANTAGONIST ENVEDA THERAPEUTICS, INC. (US) 2024-11-21 WO disclosed